(MENAFN- Live Mint) Maharashtra reported two more deaths on Friday due to the Guillain-Barre Syndrome , which is an immunological nerve disorder, commonly known as the GBS virus, taking the total fatalities to four, reported ANI.
According to the details, the new deaths were reported each from Pimpri-Chinchwad and Pune. He has been identified as 36-year-old male from Pimplegurav, who worked as an Ola-Uber driver.
The victim was admitted to Yashwantrao Chavan Hospital on January 21 due to suspected Guillain-Barre Syndrome (GBS).
As per the press note issued by the health department of Pimpri Chinchwad Municipal Corporation on Friday, the patient's health deteriorated, and he passed away on January 30, 2025.
"The deceased was also diagnosed with Guillain-Barre Syndrome. A nerve conduction test was performed on January 22," ANI quoted the statement as saying.
Further, it was stated that the committee cited the following reasons for the death: "Immediate cause of death: Severe acute respiratory distress syndrome, Antecedent cause of death: Bilateral pneumonia, Other significant condition: Guillain-Barre Syndrome."
So far, Pune has reported the maximum cases of the GBS virus, with as many as 130 people diagnosed with the same till January 30 in the state.
Out of these, 73 patients have been confirmed as having GBS, 25 patients are from Pune Municipal Corporation, 74 from newly added villages in the PMC area, 13 from Pimpri Chinchwad Municipal Corporation, 9 from Pune Rural, and 9 from other districts. Among the affected individuals, 20 are currently on ventilator support, added the report.
Union Health Ministry deputes team:
To aid state authorities in instituting interventions and managing the spurt in suspected and confirmed cases of GBS in the city, the Union Health Ministry has deputed a high-level multi-disciplinary team to Pune.
MENAFN31012025007365015876ID1109152190
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.